Totality is proud to have been asked to participate in a new study by the makers of Varithena, the British Technology Group. As the first and only vein care center in Oklahoma to currently use Varithena in the treatment of varicose veins, we were one of the first centers in the country to be asked to participate in this ground-breaking research. During the course of the study, we will be helping to investigate the benefit of Varithena in potentially accelerating ulcer healing, reducing ulcer recurrence, and improving the quality of life for patients with chronic venous insufficiency and venous leg ulcers.
Totality Participates in Varithena Study
